Biohaven Pharmaceutical H... (BHVN)
undefined
undefined%
At close: undefined
38.47
0.00%
After-hours Dec 13, 2024, 07:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY17
Revenue - - 462.51M - - -
Cost of Revenue 3.37M 1.39M 91.66M 72.00K - -
Gross Profit -3.37M -1.39M 370.85M -72.00K - -
Operating Income -436.05M -567.93M -218.90M -114.51M -479.12M -
Interest Income 17.73M - - - - -
Pretax Income -409.55M -569.84M -212.43M -118.67M -528.39M -
Net Income -408.17M -570.28M -213.80M -118.67M -528.80M -
Selling & General & Admin 62.77M 130.86M 37.41M 16.05M 134.45M -
Research & Development 373.28M 437.07M 181.49M 98.46M 344.67M -
Other Expenses - -1.91M 1.21M - - -
Operating Expenses 436.05M 567.93M 218.90M 114.51M 479.12M -
Interest Expense - - - - -12.71M -
Selling & Marketing Expenses 5.87M - - - - -
Cost & Expenses 436.05M 567.93M 218.90M 114.51M 479.12M -
Income Tax -1.38M 438.00K 1.37M -134.30K 419.00K -
Shares Outstanding (Basic) 71.20M 44.74M 35.82M 35.82M 48.49M -
Shares Outstanding (Diluted) 71.20M 44.74M 35.82M 35.82M 48.49M -
EPS (Basic) -5.73 -12.75 -5.97 -3.31 -10.91 -
EPS (Diluted) -5.73 -12.75 -5.97 -3.31 -10.91 -
EBITDA -429.14M -462.80M -217.51M -114.43M -479.12M -
Depreciation & Amortization 6.91M 1.39M 1.39M 72.00K 171.86K 52.52K